查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827526

乳房摄影影像市场（按产品、技术、设备类型、类别、影像方式、应用和最终用户划分）—2025-2032 年全球预测

Breast Imaging Market by Product, Technology, Equipment Type, Category, Imaging Modality, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，乳房摄影影像市场规模将成长至 103.5 亿美元，复合年增长率为 8.46%。

主要市场统计数据
基准年2024年 54亿美元
预计2025年 58.3亿美元
预测年份：2032年 103.5亿美元
复合年增长率（%） 8.46%

重新定义乳房摄影采购、部署和护理途径的临床要求和技术进步的权威指导

乳房摄影领域正经历技术快速成熟、临床重点趋同以及政策审查日益严格等诸多变化，这些变化正在重新定义医疗服务提供者、支付方和供应商的检测和诊断方式。影像硬体和软体的最新进展，包括多维成像技术的改进以及先进放射学工作流程的整合，正在重塑从筛检到术前定位的临床路径。同时，医疗系统正在平衡资金限制与提高诊断准确性、降低召回率以及扩大医疗服务覆盖范围的需求。

相关人员正面临一系列复杂的选择：是投资模组化系统以实现模态融合，还是采用行动部署模式来扩大覆盖范围，还是优先考虑软体主导的方法来改善影像判读和互通性。这些决策受到报销趋势、放射科内部员工动态以及人工智慧作为决策支援层加速应用的影响。从类比成像到数位成像的转变等转型力量持续影响着采购週期，而监管和资费的发展也为资本规划增添了许多不确定性。

本介绍为重点执行分析奠定了基础，该分析综合了技术趋势、产品、模式和最终用户群体细分动态以及区域见解，为战略规划提供信息，目的是让决策者对重塑乳房摄影的力量有清晰、可行的理解，并使他们能够优先考虑能够产生临床影响和运营弹性的投资。

模式创新、软体整合和分散式护理模式正在重塑乳房摄影影像的诊断途径和操作重点

乳房摄影领域正在经历重大变革，这得益于显像模式的进步、软体支援的工作流程以及不断变化的医疗服务模式，这些模式提高了诊断的准确性和操作的灵活性。三维和高维度显像模式改善了病变特征的描述和手术计划，而造影技术和混合方法则提高了复杂临床场景中的灵敏度。同时，软体创新，例如针对断层合成和MRI优化的影像处理软体以及简化工作流程和决策支援的放射学软体，已成为硬体投资的重要补充。

另一个重大变化是向分散式医疗模式的转变。行动医疗单元和整合系统使筛检和追踪服务能够在传统医院环境之外进行，从而扩大了医疗服务的可近性并提高了医疗服务的连续性。随着系统将影像输出与电子健康记录和多学科医疗平台相集成，这种营运模式的转变与对互通性和资料管治的日益重视不谋而合。同时，人力限制和人工智慧辅助工具的普及迫使医疗系统重新设计放射科工作流程，以提高诊疗效率并维持品质。

这些转变凸显了乳房摄影影像价值的重新定义：成功不再仅仅透过设备效能来衡量，而是透过提供全面的、以患者为中心的诊断途径的能力来衡量，该途径结合了多种模式、无缝软体整合和自适应部署策略，以满足不断变化的临床需求。

不断变化的关税政策如何重塑供应链、筹资策略和供应商关係，以优先考虑弹性和总拥有成本

美国近期颁布的关税政策对服务于乳房摄影生态系统的整个供应链产生了累积影响，影响了采购时间表、筹资策略和供应商谈判。依赖全球化製造布局的设备製造商已经调整了其供应链架构，以缓解不断上涨的投入成本和关税，这导致他们重新定位零件采购、重组产品组合，在某些情况下甚至转移生产地点以保持竞争力。

医疗系统和诊断中心正在重新思考其采购视角，强调整体拥有成本和生命週期支持，而不是仅仅关注领先资本支出。这导致人们对融资模式、延长服务协议和以旧换新计划的兴趣日益浓厚，旨在分散财务影响并保持对先进影像处理功能的使用。此外，供应商越来越多地在设计产品系列考虑模组化，以实现增量升级，从而降低关税引发的价格波动的影响。

同时，关税环境正在加速围绕近岸外包和供应商多元化的对话，促使相关人员优先考虑拥有韧性本地供应链和强大售后服务支援网络的合作伙伴。这种方向的转变反映出人们越来越认识到，政策主导的成本压力需要采取灵活的筹资策略，加强临床团队与供应链领导者之间的合作，并製定积极主动的合约安排，以保障医疗服务的连续性和资本规划。

综合細項分析揭示了产品、技术、设备、模式、应用和最终用户动态如何融合以形成策略机会

市场区隔洞察表明，市场动态是多方面的，反映了产品、技术、设备类型、类别、显像模式、应用和最终用户的不同驱动因素。系统包括切片检查引导、乳房核磁共振成像 (MRI)、超音波、乳房 X 光乳房X光摄影和断层合成设备，而软体则包括针对特定模式定制的影像处理平台和放射学解决方案，以提高工作流程效率和诊断一致性。这种交互作用表明，对先进系统的投资通常需要对软体进行同步投资，以最大限度地提高临床价值。

技术碎片化凸显了向多维成像的转变，3D 和新兴的 4D 技术被纳入临床工作流程，以提高病变的可视性和运动特征。考虑设备类型时，应重点考虑以下选项：专为全面工作流程设计的整合系统、可扩展至区域环境的行动单元，以及以较低的资本投入提供专用功能的独立设备。类比成像和数位成像之间的差异将继续影响升级週期和互通性要求。

显像模式细分涵盖乳房断层合成、造影乳房X光摄影、数位乳房X光摄影、核磁共振成像、乳房摄影影像和超音波等多种影像方式。终端使用者细分涵盖门诊手术中心、癌症研究中心、诊断影像中心和医院，每个中心的营运约束、监管要求和实施路径各不相同。整合这些细分层级，可以揭示临床需求与营运可行性之间的契合点，为供应商和服务提供者识别具有高影响力的商机。

美洲、欧洲、中东和非洲以及亚太地区的部署细节将决定采用和规模策略

区域动态正在影响三大宏观区域（美洲、欧洲、中东和非洲以及亚太地区）的投资重点、技术采用和营运策略。在美洲，投资的驱动因素包括：设施整合、对筛检专案优化的关注，以及私人企业的积极进入，这些企业正在加速采用断层合成技术和先进的软体平台。同时，监管更新和报销改革正在推动医疗机构对其影像处理资产进行现代化升级，并采用各种工具来降低召回率并提高诊断信心。

欧洲、中东和非洲的市场格局多元。西欧市场持续优先考虑数位转型以及显影剂和磁振造影技术的整合，而中东和非洲市场则往往强调行动筛检计划，并透过投资扩充性的诊断影像系统来扩大可及性。这种多元化的市场格局需要製定针对特定区域的市场策略，以应对复杂的监管环境和不同程度的基础设施成熟度。在亚太地区，快速的都市化和不断增长的医疗保健投资正在推动对高端医疗设备和便利筛检解决方案的需求。本地生产和强大的区域供应商生态系统也在影响采购动态，从而能够提供针对公共和私营部门需求的具有竞争力的产品。

在全部区域，策略重点集中在互通性、劳动力发展和路径优化上，但每个地区都有不同的监管、经济和基础设施因素组合，需要采用独特的部署方法、伙伴关係模式和临床培训计画。

供应商差异化、伙伴关係和卓越服务如何提升竞争优势并影响不同临床环境中的采用

乳房摄影影像领域的竞争格局由传统设备製造商、创新软体供应商以及专注于特定设备解决方案的新兴专家组成。老字型大小企业继续利用其规模、服务网络以及涵盖乳房X光摄影X光检查、超音波、核磁共振成像和断层合成系统的广泛产品系列，以保持其在医院和大型诊断中心的影响力。同时，软体公司正透过工作流程自动化、人工智慧驱动的检测和分类功能以及促进远端读取和多学科协作的云端基础架构来脱颖而出。

新参与企业和细分领域的专家正在透过开发针对行动筛检优化的模组化设备、用于分散式护理的经济高效的独立设备以及针对难诊人群的显影剂和分子成像解决方案来填补市场空白。伙伴关係关係和联盟日益普遍，供应商合作整合影像处理软体和系统硬件，并共同进行临床检验研究，以证明其在现实世界中的影响。供应商正专注于快速维护回应、培训计划和灵活的资金筹措减少停机时间并保障临床吞吐量。

总的来说，这些企业级动态凸显了互通性、证据产生和售后参与的重要性，因为在临床结果和营运连续性驱动购买决策的市场中，它们是差异化因素。

采取切实可行的优先策略行动，协调采购、技术整合和员工准备，以加速临床影响和营运弹性

寻求抓住市场机会的产业领导者应优先制定一系列切实可行的策略，将技术投资与临床工作流程和业务目标结合。首先，投资可互通的解决方案，以实现影像处理系统与放射学软体之间的无缝集成，支援多学科护理路径，并促进人工智慧的扩展。优先考虑开放标准和可扩展架构，将有助于组织为未来的应用做好准备，并减少升级显像模式和工作流程工具时的摩擦。

第二，采用灵活的采购和资金筹措结构，平衡资金限制和临床需求。这包括考虑模组化升级路径、託管服务协议和资产生命週期伙伴关係，以降低前期成本，同时保持先进影像处理功能的使用。第三，建构具韧性的供应链和供应商生态系统，包括实现供应商多元化、优先选择拥有强大区域支持网络的合作伙伴，并纳入应急条款以缓解关税和贸易中断的影响。

最后，我们专注于人员和流程，投资于员工发展、临床培训和倡议计划，从而有效率地采用新的医疗模式和软体。透过实施这些建议，领导者可以释放更高的诊断价值，改善患者体验，并在快速发展的环境中获得永续的竞争优势。

透明的混合方法研究框架，结合初级临床医生研究、监管研究和供应链分析，产生可供决策的情报

该分析采用了严格的混合方法研究途径，将定性和定量输入进行三角测量，以确保为决策提供可靠的见解。主要研究包括结构化访谈和与临床负责人、放射科主任、采购专家和供应商高管的深入讨论，以收集关于采用驱动因素、实施挑战和服务期望的第一手观点。次要研究则包括全面检索同侪审查的临床研究、监管指南和公开的技术规范，以检验关键显像模式和软体功能的效能属性。

此外，我们还进行了供应链和政策分析，以评估关税变化和贸易动态对营运的影响，重点是製造足迹、组件依赖性和售后支援模式。此外，我们还进行了比较供应商评估，评估了产品系列、整合方法和服务提案，以确定差异化因素和潜在的合作机会。在整个过程中，我们与行业相关人员反覆检验研究结果，以确保其准确性、实用性并与不断变化的临床和监管趋势保持一致。

此方法框架确保所提出的见解基于现实世界的实践，并代表临床效用、操作可行性和对决策者的策略意义的平衡整合。

关键整合强调技术、人才和采购适应性的整合，以确保乳房摄影影像的临床卓越性和营运弹性。

总而言之，乳房摄影的未来将取决于影像模式创新、软体主导的工作流程优化以及在扩大诊疗覆盖范围的同时保持诊断品质的策略部署模式的相互作用。能够协调跨系统和影像软体的投资、采用灵活的采购方式并投资于员工队伍建立的医疗保健机构，将能够更好地将技术进步转化为改善的病患治疗效果。包括关税波动在内的政策变化的累积影响凸显了供应链敏捷性和供应商伙伴关係关係的必要性，这些合作伙伴关係能够在不影响服务连续性的情况下吸收成本波动。

展望未来，相关人员应关注新兴医疗模式的临床证据，优先考虑互通性以实现可扩展的人工智慧应用，并设计筹资策略以实现渐进式现代化。这将使医疗服务提供者和供应商能够携手合作，提高筛检效率、诊断准确性和以患者为中心的诊疗路径。关键在于整合技术、人员和流程，以便在快速发展中保持卓越的临床表现和营运韧性。

目录

第一章 引言

第二章分析方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合人工智慧演算法，实现乳房X光检查病变的自动检测与分类
  • 结合 3D 断层合成和显影剂增强技术可提高緻密乳房组织中的癌症检测率
  • 具有靶向放射性示踪剂的分子乳房摄影越来越多地被用于提高筛检高风险患者的特异性。
  • 开发可携式手持超音波设备，用于乳房病变的照护现场评估
  • 扩展融合成像工作流程，整合超音波和 MRI 数据，实现全面的肿瘤表征
  • 基于深度学习的分割工具的实现，用于自动化乳房组织密度量化和风险分层
  • 低剂量频谱X光检查系统的出现，可提供双能量影像，且不增加辐射曝射量
  • 远距乳房 X 光摄影平台的兴起，使得医疗服务不足和农村地区的医疗保健环境能够进行远端读取和咨询
  • 加强诊断影像中心与生技公司的合作，开发新的乳癌生物标记

第六章：美国关税的累积影响（2025年）

第七章：人工智慧（AI）的累积影响（2025年）

第八章乳房摄影诊断市场（按产品）

  • 软体
    • 诊断影像软体
    • 放射学软体
  • 系统
    • 切片检查引导系统
    • 乳房MRI系统
    • 乳房超音波系统
    • 乳房钼靶X光摄影系统
    • 断层合成系统

第九章乳房摄影影像市场（按技术）

  • 二维影像诊断
  • 3D影像诊断
  • 4D影像诊断

第 10 章乳房摄影诊断市场（依设备类型）

  • 整合系统
  • 移动单元
  • 独立设备

第11章乳房摄影诊断市场分类

  • 类比成像
  • 数位影像

第 12 章乳房摄影影像市场（依影像方式）

  • 乳房断层摄影
  • 造影X光摄影
  • 数位乳房摄影
  • 磁振造影
  • 分子乳房摄影
  • 超音波影像

第十三章乳房摄影诊断市场应用

  • 乳房切片
  • 诊断性乳房X光检查
  • 术前位置估计
  • 乳房X筛检

第14章乳房摄影诊断市场（依最终用户）

  • 门诊手术中心
  • 癌症研究中心
  • 诊断影像中心
  • 医院

第十五章乳房摄影诊断市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章乳房摄影诊断市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章乳房摄影诊断市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Agfa-Gevaert Group
    • Analogic Corporation
    • Aurora Health, Inc.
    • Canon Inc.
    • Carestream Health Inc.
    • CMR Naviscan Corporation
    • Delphinus Medical Technologies, Inc.
    • EIZO Corporation
    • Elekta AB
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Hitachi Ltd.
    • Hologic, Inc.
    • IMS Giotto SpA
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Micrima Limited
    • Mindray Medical International Limited
    • Neusoft Medical Systems Co., Ltd.
    • Planmeca OY
    • Samsung Electronics Co., Ltd.
    • Sectra AB
    • Shanghai United Imaging Healthcare Co., LTD
    • Shimadzu Corporation
    • Siemens Healthineers AG
    • Sonosdetect LLC
    • Trivitron Healthcare Private Limited
Product Code: MRR-43395F955F76

The Breast Imaging Market is projected to grow by USD 10.35 billion at a CAGR of 8.46% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.40 billion
Estimated Year [2025] USD 5.83 billion
Forecast Year [2032] USD 10.35 billion
CAGR (%) 8.46%

An authoritative orientation to clinical imperatives and technological evolution redefining procurement, deployment, and care pathways in breast imaging

The breast imaging landscape is experiencing rapid technological maturation, converging clinical priorities, and heightened policy scrutiny that together redefine how providers, payers, and vendors approach detection and diagnosis. Recent advances in imaging hardware and software, including the refinement of multi-dimensional imaging techniques and the integration of advanced radiology workflows, are reshaping clinical pathways from screening through pre-surgical localization. At the same time, health systems are balancing capital constraints with imperatives to improve diagnostic accuracy, reduce recall rates, and expand access to underserved populations.

In practice, stakeholders are contending with a complex matrix of choices: whether to invest in modular systems that enable modality convergence, adopt mobile deployment models to increase reach, or prioritize software-driven improvements in image interpretation and interoperability. These decisions are influenced by reimbursement trajectories, workforce dynamics within radiology, and the accelerating adoption of artificial intelligence as a decision-support layer. Transitional forces such as migration from analog to digital imaging continue to influence procurement cycles, while regulatory and tariff developments add layers of uncertainty to capital planning.

This introduction sets the stage for a focused executive analysis that synthesizes technology trends, segmentation dynamics across product, modality, and end-user groups, and regional considerations that will inform strategic planning. The goal is to equip decision-makers with a clear, actionable understanding of the forces reshaping breast imaging so they can prioritize investments that deliver clinical impact and operational resilience.

Converging modality innovation, software integration, and distributed care models that are reshaping diagnostic pathways and operational priorities across breast imaging

The landscape of breast imaging is undergoing transformative shifts driven by advances in imaging modalities, software-enabled workflows, and changes in care delivery models that are collectively elevating diagnostic precision and operational flexibility. Three-dimensional and higher-dimensional imaging modalities are improving lesion characterization and surgical planning, while contrast-enhanced techniques and hybrid approaches are enhancing sensitivity in complex clinical scenarios. Concurrently, software innovation-spanning imaging software optimized for tomosynthesis and MRI, alongside radiology software that streamlines workflow and decision support-has become an essential complement to hardware investments.

Another pivotal shift is the movement toward distributed models of care, where mobile units and integrated systems enable screening and follow-up services outside of traditional hospital settings, expanding access and improving continuity of care. This operational transition is matched by a growing emphasis on interoperability and data governance as systems integrate imaging outputs with electronic health records and multidisciplinary care platforms. Meanwhile, workforce constraints and the proliferation of AI-assisted tools are prompting health systems to redesign radiology workflows to maintain quality while increasing throughput.

Together, these shifts underscore a redefinition of value in breast imaging: success is no longer measured solely by equipment capabilities but by the ability to deliver integrated, patient-centered diagnostic pathways that combine modality diversity, seamless software integration, and adaptive deployment strategies to meet evolving clinical needs.

How evolving tariff policies have reshaped supply chains, procurement strategies, and vendor relationships to prioritize resilience and total cost of ownership

Recent tariff policies enacted by the United States have introduced cumulative effects across supply chains that serve the breast imaging ecosystem, influencing procurement timelines, sourcing strategies, and vendor negotiations. Equipment manufacturers that rely on globalized manufacturing footprints have adjusted their supply chain architectures to mitigate increased input costs and customs duties, which has led to a reallocation of component sourcing, reengineering of product configurations, and, in some cases, shifts in production locations to preserve competitiveness.

Health systems and diagnostic centers have responded by re-evaluating procurement horizons, placing greater emphasis on total cost of ownership and lifecycle support rather than upfront capital expenditure alone. As a result, there is heightened interest in financing models, extended service agreements, and trade-in programs that spread financial impact and maintain access to advanced imaging capabilities. Furthermore, vendors are increasingly designing product portfolios with modularity in mind to enable phased upgrades that are less sensitive to tariff-induced price volatility.

In parallel, the tariff environment has accelerated dialogues around nearshoring and supplier diversification, prompting stakeholders to prioritize partners with resilient regional supply chains and robust after-sales support networks. This reorientation reflects a broader recognition that policy-driven cost pressures require adaptive procurement strategies, closer collaboration between clinical teams and supply chain leaders, and proactive contractual arrangements to safeguard continuity of care and capital planning.

Integrated segmentation analysis revealing how product, technology, equipment, modality, application, and end-user dynamics converge to shape strategic opportunities

Segmentation insights reveal that the market's dynamics are multifaceted, reflecting distinct drivers across products, technologies, equipment types, categories, imaging modalities, applications, and end users. From a product perspective, systems and software play complementary roles: systems encompass biopsy guidance, breast MRI, ultrasound, mammography, and tomosynthesis equipment, while software spans imaging platforms tailored to specific modalities and radiology solutions that enhance workflow efficiency and diagnostic consistency. This interplay illustrates how investment in advanced systems often necessitates parallel spending on software to unlock full clinical value.

Technology segmentation underscores a shift toward multidimensional imaging, with 3D and emerging 4D techniques increasingly integrated into clinical workflows to improve lesion conspicuity and motion characterization, while 2D imaging remains a core component of many screening programs. Equipment type considerations highlight choices among integrated systems designed for comprehensive workflows, mobile units that extend reach into community settings, and standalone devices that deliver targeted functionality with lower capital intensity. The category distinction between analog and digital imaging continues to shape upgrade cycles and interoperability requirements, as institutions prioritize digital conversion to enable image sharing and AI applications.

Imaging modality segmentation reveals a broad portfolio across breast tomosynthesis, contrast-enhanced mammography, digital mammography, MRI, molecular breast imaging, and ultrasound, each offering unique clinical advantages that inform application-specific deployment for biopsy, diagnostic mammography, pre-surgical localization, and screening. End-user segmentation spans ambulatory surgical centers, cancer research centers, diagnostic imaging centers, and hospitals, and each setting imposes distinct operational constraints, regulatory obligations, and adoption pathways. Synthesizing these segmentation layers clarifies where clinical demand meets operational feasibility and identifies high-impact opportunities for vendors and providers alike.

Regional deployment nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored strategies for adoption and scale

Regional dynamics are influencing investment priorities, technology adoption, and operational strategies across three macro regions: Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, investment is often driven by a combination of institutional consolidation, emphasis on screening program optimization, and active private sector participation that accelerates adoption of tomosynthesis and advanced software platforms. Meanwhile, regulatory updates and reimbursement recalibrations encourage providers to modernize imaging fleets and incorporate tools that reduce recall rates and enhance diagnostic confidence.

In Europe, Middle East & Africa, the environment is diverse: Western European markets continue to prioritize digital transformation and integration of contrast-enhanced and MRI-based techniques, while markets in the Middle East and Africa often focus on expanding access through mobile screening initiatives and investment in scalable imaging systems. This heterogeneous landscape necessitates region-specific go-to-market strategies that account for regulatory complexity and variable infrastructure maturity. In Asia-Pacific, rapid urbanization and expanding healthcare investment are driving demand for both high-end modalities and accessible screening solutions. Local manufacturing and strong regional supplier ecosystems are also influencing procurement dynamics, enabling competitive product offerings that target both public and private sector needs.

Across these regions, strategic priorities converge around interoperability, workforce development, and pathway optimization, yet each region's unique combination of regulatory, economic, and infrastructure factors requires tailored approaches to deployment, partnership models, and clinical training programs.

How vendor differentiation, partnerships, and service excellence are driving competitive advantage and influencing adoption across diverse clinical settings

Competitive dynamics in the breast imaging arena are shaped by a mix of legacy equipment manufacturers, innovative software vendors, and emerging specialists focused on modality-specific solutions. Established players continue to leverage scale, service networks, and broad product portfolios across mammography, ultrasound, MRI, and tomosynthesis systems to maintain footprint in hospitals and large diagnostic centers. At the same time, software companies are differentiating through workflow automation, AI-enabled detection and triage capabilities, and cloud-based architectures that facilitate remote reading and multidisciplinary collaboration.

Newer entrants and niche specialists are targeting gaps in the market by developing modular devices optimized for mobile screening, cost-effective standalone units for decentralized care, and contrast-enhanced or molecular imaging solutions that address challenging diagnostic populations. Partnerships and alliances are increasingly common, with vendors collaborating to integrate imaging software with system hardware and to co-develop clinical validation studies that demonstrate real-world impact. Service and support remain critical competitive levers, as providers place a premium on rapid maintenance response, training programs, and flexible financing that reduce downtime and protect clinical throughput.

Collectively, these company-level dynamics emphasize the importance of interoperability, evidence generation, and post-sale engagement as differentiators in a market where clinical outcomes and operational continuity govern purchasing decisions.

Practical and prioritized strategic actions that align procurement, technology integration, and workforce readiness to accelerate clinical impact and operational resilience

Industry leaders seeking to capitalize on market momentum should prioritize a set of actionable strategies that align technology investments with clinical workflows and business objectives. First, invest in interoperable solutions that enable seamless integration between imaging systems and radiology software to support multidisciplinary care pathways and facilitate AI augmentation. By prioritizing open standards and scalable architectures, organizations can future-proof deployments and reduce friction when upgrading imaging modalities or workflow tools.

Second, adopt flexible procurement and financing structures that balance capital constraints with clinical imperatives. This includes exploring modular upgrade paths, managed service agreements, and asset lifecycle partnerships that reduce upfront burdens while preserving access to advanced imaging capabilities. Third, build resilient supply chain and vendor ecosystems by diversifying suppliers, prioritizing partners with strong regional support networks, and embedding contingency clauses that mitigate tariff and trade disruptions.

Finally, focus on people and process by investing in workforce development, clinical training, and change management initiatives that enable efficient adoption of new modalities and software. Operationalizing these recommendations will help leaders unlock higher diagnostic value, improve patient experience, and achieve sustainable competitive advantage in a rapidly evolving environment.

A transparent mixed-methods research framework combining primary clinician insight, regulatory review, and supply chain analysis to produce decision-ready intelligence

This analysis draws on a rigorous, mixed-methods research approach that triangulates qualitative and quantitative inputs to ensure robust, decision-ready insights. Primary research included structured interviews and in-depth discussions with clinical leaders, radiology directors, procurement specialists, and vendor executives to capture first-hand perspectives on adoption drivers, deployment challenges, and service expectations. Secondary research involved comprehensive review of peer-reviewed clinical studies, regulatory guidance, and publicly available technical specifications to validate performance attributes of key imaging modalities and software capabilities.

Additionally, supply chain and policy analyses were conducted to assess the operational implications of tariff changes and trade dynamics, focusing on manufacturing footprints, component dependencies, and aftermarket support models. Comparative vendor assessments evaluated product portfolios, integration approaches, and service propositions to identify differentiation factors and potential partnership opportunities. Throughout the process, findings were iteratively validated with industry stakeholders to ensure accuracy, practical relevance, and alignment with evolving clinical and regulatory trends.

This methodological framework ensures that the insights presented are grounded in real-world practice and reflect a balanced synthesis of clinical utility, operational feasibility, and strategic implications for decision-makers.

A decisive synthesis emphasizing integration of technology, people, and procurement adaptability to secure clinical excellence and operational resilience in breast imaging

In conclusion, the future of breast imaging will be determined by the interplay between modality innovation, software-driven workflow optimization, and strategic deployment models that extend access while preserving diagnostic quality. Institutions that align investments across systems and imaging software, adopt flexible procurement approaches, and invest in workforce readiness will be better positioned to translate technological advances into improved patient outcomes. The cumulative effects of policy shifts, including tariff dynamics, underscore the need for supply chain agility and vendor partnerships that can absorb cost variability without compromising service continuity.

Looking forward, stakeholders should remain attentive to the clinical evidence base around emerging modalities, prioritize interoperability to enable scalable AI adoption, and design procurement strategies that accommodate phased modernization. By doing so, providers and vendors can collaboratively advance screening efficiency, diagnostic accuracy, and patient-centered care pathways. The imperative is clear: integrate technology, people, and processes in a way that sustains both clinical excellence and operational resilience amidst a period of rapid evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated lesion detection and classification in mammography
  • 5.2. Adoption of 3D tomosynthesis combined with contrast enhancement for improved cancer detection in dense breast tissue
  • 5.3. Growing use of molecular breast imaging with targeted radiotracers to improve specificity in high-risk patient screening
  • 5.4. Development of portable handheld ultrasound devices with AI guidance for point-of-care breast lesion assessment
  • 5.5. Expansion of fusion imaging workflows integrating ultrasound and MRI data for comprehensive tumor characterization
  • 5.6. Implementation of deep learning-based segmentation tools for automated breast tissue density quantification and risk stratification
  • 5.7. Emergence of low-dose spectral mammography systems offering dual-energy imaging without increasing radiation exposure
  • 5.8. Rise of telemammography platforms enabling remote reading and consultation in underserved or rural healthcare settings
  • 5.9. Introduction of contrast-enhanced mammography protocols to reduce false negatives in early-stage tumor screening
  • 5.10. Increasing collaboration between imaging centers and biotech firms for development of novel breast cancer biomarkers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Imaging Market, by Product

  • 8.1. Software
    • 8.1.1. Imaging Software
    • 8.1.2. Radiology Software
  • 8.2. Systems
    • 8.2.1. Biopsy Guidance Systems
    • 8.2.2. Breast MRI Systems
    • 8.2.3. Breast Ultrasound Systems
    • 8.2.4. Mammography Systems
    • 8.2.5. Tomosynthesis Systems

9. Breast Imaging Market, by Technology

  • 9.1. 2D Imaging
  • 9.2. 3D Imaging
  • 9.3. 4D Imaging

10. Breast Imaging Market, by Equipment Type

  • 10.1. Integrated Systems
  • 10.2. Mobile Units
  • 10.3. Standalone Devices

11. Breast Imaging Market, by Category

  • 11.1. Analog Imaging
  • 11.2. Digital Imaging

12. Breast Imaging Market, by Imaging Modality

  • 12.1. Breast Tomosynthesis
  • 12.2. Contrast Enhanced Mammography
  • 12.3. Digital Mammography
  • 12.4. Magnetic Resonance Imaging
  • 12.5. Molecular Breast Imaging
  • 12.6. Ultrasound Imaging

13. Breast Imaging Market, by Application

  • 13.1. Breast Biopsy
  • 13.2. Diagnostic Mammography
  • 13.3. Pre-Surgical Localization
  • 13.4. Screening Mammography

14. Breast Imaging Market, by End-User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Cancer Research Centers
  • 14.3. Diagnostic Imaging Centers
  • 14.4. Hospitals

15. Breast Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Breast Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Breast Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Agfa-Gevaert Group
    • 18.3.2. Analogic Corporation
    • 18.3.3. Aurora Health, Inc.
    • 18.3.4. Canon Inc.
    • 18.3.5. Carestream Health Inc.
    • 18.3.6. CMR Naviscan Corporation
    • 18.3.7. Delphinus Medical Technologies, Inc.
    • 18.3.8. EIZO Corporation
    • 18.3.9. Elekta AB
    • 18.3.10. Esaote S.p.A.
    • 18.3.11. FUJIFILM Holdings Corporation
    • 18.3.12. GE HealthCare
    • 18.3.13. Hitachi Ltd.
    • 18.3.14. Hologic, Inc.
    • 18.3.15. IMS Giotto S.p.A.
    • 18.3.16. Konica Minolta, Inc.
    • 18.3.17. Koninklijke Philips N.V.
    • 18.3.18. Micrima Limited
    • 18.3.19. Mindray Medical International Limited
    • 18.3.20. Neusoft Medical Systems Co., Ltd.
    • 18.3.21. Planmeca OY
    • 18.3.22. Samsung Electronics Co., Ltd.
    • 18.3.23. Sectra AB
    • 18.3.24. Shanghai United Imaging Healthcare Co., LTD
    • 18.3.25. Shimadzu Corporation
    • 18.3.26. Siemens Healthineers AG
    • 18.3.27. Sonosdetect LLC
    • 18.3.28. Trivitron Healthcare Private Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BREAST IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BREAST IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BREAST IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA BREAST IMAGING MA